Western Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Western Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,265	Closed	-$365K	–	618
2022 Q3	$365K	Sell	11,265 -270	-2%	-$9.91K	0.02%	584
2022 Q2	$362K	Sell	11,535 -9,484	-45%	-$332K	0.02%	555
2022 Q1	$966K	Buy	21,019 +9,710	+86%	+$463K	0.05%	341
2021 Q4	$692K	Buy	+11,309	New	+$782K	0.07%	267
2021 Q2	$910K	Sell	9,856 -304	-3%	-$25.8K	0.09%	227
2021 Q1	$901K	Buy	10,160 +4,154	+69%	+$412K	0.12%	180
2020 Q4	$560K	Buy	6,006 +1,050	+21%	+$83.7K	0.08%	233
2020 Q3	$316K	Buy	+4,956	New	+$290K	0.05%	327

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Western Wealth Management's ARKG Position: Q4 2022 in Review

Western Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 11,265 shares — an estimated $365K sold.

Western Wealth Management first reported a position in ARKG in Q3 2020 and held it in 8 quarters. The position peaked at $966K in Q1 2022. 321 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

Western Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
Western Wealth Management sold 11,265 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $365K.
Western Wealth Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 8 quarters.
Western Wealth Management's ARK Genomic Revolution ETF position peaked at $966K in Q1 2022.
321 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Western Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.